Charles Schwab stock climbs after earnings as Forge vote clears a hurdle and Fed week nears

Charles Schwab stock climbs after earnings as Forge vote clears a hurdle and Fed week nears

Charles Schwab shares rose 2.2% to $104.05 in after-hours trading Thursday after posting a 19% jump in fourth-quarter net revenue to $6.34 billion. Shareholders approved proposals for Schwab’s planned Forge Global merger, but regulatory clearance is still pending. Schwab ended 2025 with $11.90 trillion in client assets. Investors are watching next week’s Federal Reserve meeting for rate signals.
Disney stock price stalls near $113 as proxy filing puts CEO pick in “early 2026” focus

Disney stock price stalls near $113 as proxy filing puts CEO pick in “early 2026” focus

Disney shares were little changed after hours Thursday following a proxy filing setting its annual meeting for March 18 and revealing the board aims to name a new CEO in early 2026. The filing also highlighted $1.3 billion in streaming profit for fiscal 2025 and $3.5 billion in share buybacks. Chief People Officer Sonia L. Coleman plans to sell 2,473 shares. Disney will report fiscal Q1 earnings on Feb. 2.
U.S. Bancorp stock flirts with a 52-week high as bond sale and Fed week come into view

U.S. Bancorp stock flirts with a 52-week high as bond sale and Fed week come into view

U.S. Bancorp shares rose 1.28% to $56.18 Thursday, closing just below a 52-week high after the bank priced $1.25 billion in fixed-to-floating senior notes maturing in 2032. The company reported a 23% jump in Q4 profit to $2.05 billion and expects 2026 revenue growth of 4% to 6%. Investors await the Federal Reserve’s Jan. 27-28 meeting for signals on rates.
Pfizer stock price edges up — what PFE investors are watching after vaccine policy shifts

Pfizer stock price edges up — what PFE investors are watching after vaccine policy shifts

Pfizer shares closed up 0.8% at $26.10 Thursday, trading between $25.75 and $26.31. The gain followed news of a non-exclusive deal with Novavax for access to its Matrix‑M adjuvant, worth $30 million upfront. U.S. officials have reversed universal vaccine recommendations, shifting to “shared clinical-decision-making.” Pfizer CEO Albert Bourla blamed policy rhetoric for falling vaccination rates.
Constellation Energy (CEG) stock price slides toward $287 — what to watch before Friday’s open

Constellation Energy (CEG) stock price slides toward $287 — what to watch before Friday’s open

Constellation Energy shares fell 2.4% to $287.35 Thursday, closing near session lows despite broader market gains. Wells Fargo cut its price target to $460 but kept an Overweight rating. The drop followed PJM’s emergency auction plan and new rules for large power users as a cold snap threatens peak demand. About 4.7 million shares traded hands.
Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares rose 0.4% to $525.81 in after-hours trading Thursday after quarterly earnings beat forecasts. The company reported a 19% revenue increase to $2.87 billion, with da Vinci procedures up 17%. Intuitive projects 13%-15% da Vinci procedure growth in 2026 but warned tariffs could cut margins. Investors remain focused on procedure growth and tariff impacts ahead of Friday’s session.
Texas Instruments stock edges up after-hours as BNP Paribas upgrades TXN, Susquehanna lifts target

Texas Instruments stock edges up after-hours as BNP Paribas upgrades TXN, Susquehanna lifts target

Texas Instruments shares rose 0.3% to $194.99 in after-hours trading Thursday after BNP Paribas upgraded the stock to Neutral and Susquehanna raised its price target to $225. The moves come ahead of the company’s Jan. 27 earnings call, with investors watching for signs of recovery in industrial chip demand and continued weakness in auto.

Stock Market Today

Go toTop